CARREFOUR COLLABORATIF DE FORMATION
Le Carrefour collaboratif de formation est une plateforme, en libre accès, offerte à nos partenaires et collaborateurs, où chacun peut accéder à plus de contenu de formation sur les essais cliniques. Chaque mini-série vous offre une sélection de contenu d’apprentissage de haute qualité produit par, ou en collaboration avec, ou par d’autres leaders canadiens dans le domaine des essais cliniques. Toutes les formations sont offertes à la demande, sur ordinateur, sur tablette et sur téléphone cellulaire, sans inscription.
Avez-vous une offre de formation ou une ressource qui pourrait être hébergée sur notre Carrefour collaboratif de formation ? Des idées de contenu ou de partenariats potentiels ? Envoyez-nous un courriel à communication@wecantrain.ca
CBITN
DISCLAIMER: Captions are automatically generated and may not be fully accurate
Towards an integrated framework for designing and testing behaviour change interventions
Prof. Simon L. Bacon, Concordia University (Canada)
________
This modules focuses on some of the major limitations in current behavioural intervention studies, explores the process of generating and testing a behavioural intervention as well as some key questions to ask of behavioural intervention studies.
46 min
Required pre-readings
Designing Effective Health Behaviour Change Interventions: Using the Behaviour Change Wheel and Beyond
Asst. Prof. Marta Marques, NOVA University of Lisbon (Portugal)
________
This modules focuses on behaviour change techniques and on differentiating frameworks, models and classification systems applicable to behaviour change interventions, explores the Behaviour Change Wheel framework and the COM-B Model of Behaviour Change, and discusses the importance of specifying and classifying components of behaviour change interventions during their development.
47 min
Required pre-readings
A Review and Comparison of Behavioral Intervention Development Frameworks: The ORBIT Model, The Science of Behavior Change (SOBC) approach, and the MRC framework
Susan M. Czajkowski, Chief of the Health Behaviors Research Branch – Division of Cancer Control and Population Sciences, National Cancer Institute (USA)
________
This module focuses on the goals and purposes of three behavioral intervention development and testing approaches, explore the key features and relationships between each of these frameworks, and also explore how best to select frameworks for the development of specific interventions.
50 min
Required pre-readings
Clinical Behavioural Trial Designs (e.g, adaptive/SMART, Pragmatic, n of 1, etc)
Assoc. Prof. Sylvie Lambert, McGill University (Canada)
________
This module focuses on evaluating behavioural interventions through different trial designs, exploring alternative trial designs used to evaluate components of a behavioral intervention and overviewing the strengths and weaknesses of each of the explored trial designs.
59 min
Required pre-readings
Outcome selection in behavioural trials: Challenges and opportunities
Prof. Kim Lavoie, Université du Québec à Montréal (Canada)
________
This module focuses on different types of trial outcomes and their purposes, the unique challenges associated with selecting outcomes for behavioural trials, and defining the benefits of core outcome sets to improve outcome selection and reporting in behavioural trials.
29 min
Required pre-readings
Optimizing Behavioral Interventions: Introduction to MOST
Asst. Prof. Kate Guastaferro, New York University School of Global Public Health (USA)
________
This module focuses on the rationale for, and process of, intervention optimization via the Multiphase Optimization Strategy (MOST) and Intervention EASE approaches and making contrasts with the classical treatment package approach.
44 min
Required pre-readings
Feasibility and Pilot (F+P) Testing
Prof. Simon Bacon, Concordia University (Canada)
________
This module focuses on distinguishing between feasibility and pilot studies and exploring the knowledge gaps around these types of studies as well as reporting in relation to these two types of studies.
54 min
Required pre-readings
Assessments in Behavioural Trials: Treatment Fidelity
Prof. Kim Lavoie, Université du Québec à Montréal (Canada)
________
This modules focuses on the importance of addressing intervention fidelity within behavioural trials, understanding fidelity and its relation to adaptation, and identifying appropriate fidelity assessment strategies.
38 min
Required pre-readings
Knowledge user engagement & designing for implementation
Prof. Molly Byrne, University of Galway, Ireland (Ireland)
________
This module focuses on engaging relevant stakeholders to maximise intervention relevance, fidelity, effectiveness, and implementation; identifying implementation barriers and enablers and selecting fit-for-purpose implementation and evaluation frameworks, strategies and techniques.
38 min
Required pre-readings
Implementation Science Theories and Frameworks to Improve Translation of Research to Practice
Assoc. Prof. Justin Presseau, University of Ottawa (Canada)
________
This model focuses on implementation science, emphasizing its theories and frameworks designed to enhance the application of research findings into practical use. It outlines the differences between frameworks that help identify barriers and facilitators to implementation and those that aid in selecting effective implementation strategies.
53 min
Required pre-readings
Ika Washington, MSc., BSc, Ph.D. Student
Critical Health Sociologist, Public Health Practitioner, Patient, and Founder of Diversity Talk
SOMMET NATIONAL DE FORMATION SUR LES ESSAIS CLINIQUES 2024
AVIS DE NON-RESPONSABILITÉ : Chaque vidéo de la série est en anglais. Des sous-titres générés automatiquement en français et en anglais sont disponibles, mais peuvent ne pas être entièrement exacts.
Cette mini-série de 18 wébinaires compile pour vous les sessions complètes du Sommet de formation sur les essais cliniques 2024 de CANTRAIN, qui s’est tenu à Montréal en février dernier. Cette mini-série couvre un éventail de sujets, des avantages de l’intégration d’une perspective de sciences comportementales dans les essais cliniques, aux stratégies pour rendre les essais cliniques plus centrés sur le patient, en passant par le partage de savoirs faire dans l’élaboration et la mise en œuvre d’un cadre de compétences pour les essais cliniques. Découvrez ou redécouvrez ces séances avec des experts provenant d’un peu partout dans le domaine des essais cliniques !
| # | Presenter | Title | Duration |
|---|---|---|---|
| 01 | Pr. Linda Li, BSc(PT), PhD, FCAHS | Bright Future: Training Tomorrow’s Leaders in Patient Research Partnerships | 35 min |
| 02 | Ika Washington, MSc, BSc, PhD Student | Marginalization and Equity in Research | 30 min |
| 03 | Dr. Natalie Coburn, MD, MPH | How We Can Make Clinical Trials More Patient Centric | 41 min |
| 04a | André Pierre Picard, OC | The Future of Clinical Trials: Patient and Community Partners Perspectives | 31 min |
| 04b | André Picard, OC Dr. Linda Hunter, RN MScN, PhD(C) Alex Haagaard, BSc, MDes Dr. Natalie Coburn, MD, MPH Ika Washington, MSc., BSc, Ph.D. Student Jeniffer EJ Monaghan, BA, LLB Maureen Smith, MEd Saeideh Mayanloo, BSc Shurjeel Choudhri, BSc(med), MD, FRCPC | Panel Discussion | 69 min |
| 05 | Pr. Barbara Bierer, BSc, MD | From Theory to Practice: Development and Implementation of the JTF: Joint Task Force for Clinical Trials Competency Framework | 33 min |
| 06 | Dr. Sandra Pelaez, BEdPsy, MSc, PhD Christina Farant Monique Ostrout, BSc, DESS Katie Bainbridge, BA, MIS Dr. Linda Hunter, RN MScN, PhD(C) Mei Li, BN, MHM, PhD(C) Caroline Buote, BSc, MSc Dan Lafreniere, BSc | From the Grant to the Field: Challenges of Developing an Innovative Curriculum for Clinical Trials | 73 min |
| 07 | Munaza Jamil, BSC, CCRA | Crafting a Common Language: Standardized Role Profiles for Clinical Research Professionals in Canada | 24 min |
| 10 | Dr. Andrea Furlan, MD, PhD | De-Monopolizing Knowledge in Communities of Practice With Case-Based Learning: All Teach, All Learn | 21 min |
| 11 | Dr. Suzanne Morin, MD, MSc, FRCP, FACP Damaris Javier, MA Dr. Lisa Goos, BScH, BEd, MA, PhD | Supporting Accessibility, Diversity and Equity in Mentorship Program | 28 min |
| 12 | Dr Kieran Quinn, MD, PhD | Pragmatic Lessons in the Design of Advanced Clinical Trials | 34 min |
| 13 | Anna Heath, MMath, PhD | The Art of Biostatistics in Clinical Trials | 39 min |
| 14 | Dr. Lauren Kelly, MSc, PhD, CCRP | Increasing Capacity of Maternal and Paediatric Clinical Trials in Canada | 41 min |
| 15 | Pr. Kim Lavoie, PhD, FCPA, FABMR | Why All Trials are Behavioural Trials - Opening Remarks | 13 min |
| 16 | Pr. Simon Bacon, PhD, FTOS, FCCS, FABMR | Towards an Integrated Framework for designing and Testing Interventions Targeting Physical Activity, Diet, and Other Health Risk Behaviours: Why Some of the Major Trials Have 'Failed' and How We Can Do Better | 39 min |
| 17 | Pr. Genevieve Rouleau, MSc, PhD | Why Should We Care About Implementation Science in Health-Related Research | 29 min |
| 18 | Pr. Michael Vallis, PhD, R.Psych | How clinical trials Can Benefit From Incorporating a Behavioural Science Perspective: Challenges and Opportunities | 52 min |
Bright Future: Training Tomorrow’s Leaders in Patient Research Partnerships
(Un avenir prometteur : former les leaders de demain aux partenariats de recherche sur les patients)
Linda Li, BSc(PT), MSc, PhD, FCAHS
Senior Scientist, Implementation Science, Arthritis Research Canada
35 min
Marginalization and Equity in Research
(Marginalisation et équité dans la recherche)
Ika Washington, MSc, BSc, PhD Student
Critical Health Sociologist, Public Health Practitioner, Patient, and Founder of Diversity Talk
30 min
How We Can Make Clinical Trials More Patient Centric
(Comment pouvons-nous rendre les essais cliniques plus centrés sur le patient ?)
Natalie Coburn, MD, MPH
Senior scientist, at Sunnybrook Research Institute; Professor at University of Toronto
41 min
The Future of Clinical Trials: Patient and Community Partners Perspectives
(L'avenir des essais cliniques : perspectives des patients et des partenaires communautaires)
André Pierre Picard, OC
Reporter Health columnist, The Globe and Mail
31 min
Panel Discussion
(Table ronde)
| André Picard, OC (Moderator) | Reporter Health columnist, The Globe and Mail |
| Dr. Linda Hunter, RN MScN, PhD(C) (Chair) | National Coordinator Trialists Stream, CANTRAIN |
| PANELISTS | |
| Dr. Linda Hunter, RN MScN, PhD(C) (Chair) | National Coordinator Trialists Stream, CANTRAIN |
| Alex Haagaard, BSc, MDes | Equity-Centered Design Strategist Patient Partner, Pain BC, Co-Chair, Knowledge Mobilization and Implementation Science Committee, Chronic Pain Network |
| Dr. Natalie Coburn, MD, MPH | Senior scientist Sunnybrook Research Institute; Professor at University of Toronto |
| Ika Washington, MSc, BSc, PhD Student | Critical Health Sociologist Public Health Practitioner, Patient, and Founder of DiversityTalk |
| Jeniffer EJ Monaghan, BA, LLB | Patient Partner STROKECOG Executive Committee |
| Maureen Smith, MEd | Patient Partner Adjunct Professor, University of Toronto Dalla Lana School of Public Health, ACT Consortium, Patient Engagement & Training Committees member, Co-lead INFORM RARE Patient Engagement, IMPaCT Parent/Youth Engagement Lead |
| Saeideh Mayanloo, BSc | Site Engagement Lead AstraZeneca |
| Shurjeel Choudhri, BSc(med), MD, FRCPC | SVP and Head Medical & Scientific Affairs, Pharmaceuticals, Bayer Inc |
69 min
From Theory to Practice: Development and Implementation of the JTF: Joint Task Force for Clinical Trials Competency Framework
(De la théorie à la pratique : Élaboration et mise en œuvre du cadre de compétences du Groupe de travail conjoint pour les essais cliniques)
Barbara Bierer, BSc, MD
Faculty Director, Multi- Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard University; Director, Regulatory Foundations, Ethics and Law Program, Harvard Clinical and Translational Science Center Director, SMART IRB
33 min
From the Grant to the Field: Challenges of Developing an Innovative Curriculum for Clinical Trials
(De la subvention à la pratique : les défis du développement d'un programme d'études innovant pour les essais cliniques)
| Dr. Sandra Pelaez, BEdPsy., MSc, PhD | National Director Clinical Trials Training Programs’ Streams, CANTRAIN |
| Christina Farant | National Coordinator Graduate & Postdoctoral Trainee Stream, CANTRAIN |
| Monique Ostrout, BSc, DESS | National Coordinator Clinical Research Professionals Stream, CANTRAIN |
| Katie Bainbridge, BA, MIS | National Coordinator Trialists Stream, CANTRAIN |
| Dr. Linda Hunter, RN MScN, PhD(C) | National Coordinator Trialists Stream, CANTRAIN |
| Mei Li, BN, MHM, PhD(C) | Team Leader Clinical Research Educator, CANTRAIN |
| Caroline Buote, BSc, MSc | Team Leader Program Designer & Developer, CANTRAIN |
| Dan Lafreniere, BSc | Clinical Research Educator CANTRAIN |
73 min
Crafting a Commom Language: Standardized Role Profiles for Clinical Research Professionals in Canada
(Élaboration d’un langage commun : profils de rôle normalisés pour les professionnels de la recherche clinique au Canada)
Munaza Jamil, BSC, CCRA
McMaster Continuing Education Instructors, Faculty, Applied Clinical Research Program, McMaster University
24 min
De-Monopolizing Knowledge in Communities of Practice with Case-Based Learning: All Teach, All Learn
(Démonopoliser les connaissances dans les communautés de pratique grâce à l'apprentissage par cas : tous enseignent, tous apprennent)
Andrea Furlan, MD, PhD
Physician-Scientist, UHN – Toronto Rehabilitation Institute, CAN-TAP-TALENT
21 min
Supporting Accessibility, Diversity and Equity in Mentorship Program
(Soutenir l'accessibilité, la diversité et l'équité dans le programme de mentorat)
Damaris Javier, MA
Co-Investigator, National Research, Mentoring Network-Resource Center (NRMN-RC)
28 min
Pragmatic Lessons in the Design of Advanced Clinical Trials
(Leçons pragmatiques sur la conception d'essais cliniques avancés)
Kieran Quinn, MD, PhD
Clinician-Scientist, Sinai Health, Department of Medicine, University of Toronto, Adjunct Scientist, ICES; Clinical trials Co-lead, Pan Canadian Palliative Care Research Collaborative
34 min
The Art of Biostatistics in Clinical Trials
(L'art de la biostatistique dans les essais cliniques)
Anna Health, MMath, PhD
Scientist, Child Health and Evaluative Sciences Program, SickKids Research Institute; Assistant Professor Division of Biostatistics, University of Toronto
41 min
Increasing Capacity of Maternal and Paediatric Clinical Trials in Canada
(Accroître la capacité des essais cliniques sur les mères et les enfants au Canada)
Lauren Kelly, MSc, PhD, CCRP
National Principal Applicant, IMPaCT , Associate Professor in the Department of Pharmacology and Therapeutics, University of Manitoba
41 min
Why All Trials are Behavioural Trials - Opening Remarks
(Pourquoi tous les essais sont des essais comportementaux - Remarques préliminaires)
Kim Lavoie, PhD, FCPA, FABMR
Professor & Chair of Behavioral Medicine, University of Quebec at Montreal
13 min
Towards an Integrated Framework for Designing and Testing Interventions Targeting Physical Activity, Diet, and Other Health Risk Behaviours: Why Some of the Major Trials Have 'Failed' and How We Can Do Better
(Vers un cadre intégré pour la conception et le test d'interventions ciblant l'activité physique, l'alimentation et d'autres comportements à risque pour la santé : pourquoi certains des principaux essais ont « échoué » et comment pouvons-nous faire mieux ?)
Simon Bacon, PhD, FTOS, FCCS, FABMR
Professor and CIHR SPOR Chair in Innovative, Patient-Oriented, Behavioural Clinical Trials, Health, Kinesiology and Applied Physiology
39 min
Why Should We Care About Implementation Science in Health-Related Research
(Pourquoi devrions-nous nous intéresser à la science de la mise en œuvre dans la recherche liée à la santé)
Genevieve Rouleau, RN, MSc, PhD
Professor – Université du Québec en Outaouais; Affiliate Researcher – Institute for Health System Solutions and Virtual Care, Women’s College Hospital; Institut du Savoir Montfort
29 min
How Clinical Trials Can Benefit from Incorporating a Behavioural Science Perspective: Challenges and Opportunities
(Comment les essais cliniques peuvent bénéficier de l’intégration d’une perspective de science comportementale : défis et opportunités)
Michael Vallis, PhD, RPsych
Associated Professor, Family Medicine – Dalhousie University
52 min
Programme de formation aux essais pragmatiques
Cette mini-série en 9 parties, qui vous est proposée en collaboration avec le Programme de formation aux essais pragmatiques du Réseau de recherche sur les données de santé du Canada (RRDS Canada), sert d’introduction au Programme de formation en essais pragmatiques du RRDS Canada – une initiative pancanadienne qui offre des modules hebdomadaires en libre accès sur tous les aspects des essais pragmatiques, de la conception et de la mise en œuvre à l’analyse statistique, au contrôle de la qualité et à d’autres composantes de l’essai. La particularité de l’approche des essais pragmatiques est qu’elle vise à maximiser l’efficacité en recrutant tous les participants présentant une condition d’intérêt, en demandant au personnel de santé d’effectuer l’intervention (par opposition au personnel de recherche) et en exploitant des stratégies de collecte de données efficaces qui tirent parti des réserves existantes de données sur la santé et de données connexes, telles que celles qui sont disponibles par l’intermédiaire de réseaux comme le RRDS Canada. Plongez dans cette mini-série pour comprendre les spécificités de cette approche innovante !
Vidéos en anglais uniquement.
| # | Presenter | Title | Duration |
|---|---|---|---|
| 1 | Prof. Amit X. Garg | Welcome - Program Lead | 4 min |
| 2 | Dr. Taylor McLinden | Program Overview | 6 min |
| 3a | Prof. Amit X. Garg | Exemplar Trial Intro - EnAKT LKD | 2 min |
| 3b | Prof. Amit X. Garg, et al. | Exemplar Trial Overview - EnAKT LKD | 13 min |
| 3c | Prof. Amit X. Garg, et al. | Exemplar Trial Overview - AToM (Ambulatory Toxicity Management) | 13 min |
| 4a | Prof. Monica Kryyzanowska | Exemplar Trial - AToM | 14 min |
| 4b | Prof. Monica Kryyzanowska & Ass.Prof. Melanie Powis | Exemplar Trial - AToM | 14 min |
| 5a | Prof. Noah M. Ivers | Exemplar Trial - ISLAND | 15 min |
| 5b | Prof. Noah M. Ivers | Exemplar Trial Overview - ISLAND | 10 min |
AVIS DE NON-RESPONSABILITÉ : Chaque vidéo de la série est en anglais. Des sous-titres générés automatiquement sont disponibles, mais peuvent ne pas être entièrement exacts.
Welcome – Program Lead
Professor Amit X. Garg
MD, PhD
Pr. Amit Garg welcomes learners to the program.
4 min
Program Overview
Dr. Taylor McLinden
PhD
An overview of key details for learners accessing resources related to the program.
6 min
Exemplar Trial Intro - EnAKT LKD
Professor Amit X. Garg
MD, PhD
Introduces the Exemplar Trial Intro – EnAKT LKD pragmatic trial and the curriculum wheel.
2 min
Exemplar Trial Overview - EnAKT LKD
Professor Amit X. Garg, et al.
MD, PhD
Overviews EnAKT LKD, a pragmatic, 2-arm, parallel-group, open-label, registry-based, superiority, cluster randomized clinical trial to evaluate the effect of a multicomponent intervention designed to target several barriers that prevent eligible patients from completing key steps towards receiving a kidney transplant.
13 min
Exemplar Trial EnAKT LKD
Professor Amit X. Garg, et al.
MD, PhD
Breaks down the EnAKTLKD trial across the 12 sections of the curriculum wheel.
13 min
Exemplar Trial Overview- AToM (Ambulatory Toxicity Management)
Professor Monica Kryyzanowska
MD, MPH, FRCPC, FASCO
Overviews AToM (« Ambulatory Toxicity Management »), a multicentre pragmatic cluster randomised trial to evaluate the effect of proactive, nurse led, telephone basedmanagement of symptoms on the number of visits to the emergency department or admissions to hospital.
13 min
Exemplar Trial - AToM
Assistant-Professor Melanie Powis
BSc, MSc, PhD
Breaking down the AToM trial across the 12 sections of the curriculum wheel.
14 min
Exemplar Trial Overview - ISLAND
Professor Noah M. Ivers
MD, PhD, CCFP and co-authors
ISLAND: Three arm, pragmatic randomized trial of intervention to support long term adherence an decrease cardiovascular events – Combining data science and behavioral science to improve patient care, at scale.
10 min
Exemplar Trial - ISLAND
Professor Noah M. Ivers
MD, PhD, CCFP and co-authors
Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): Pragmatic randomised controlled trial.
15 min
eInfolettre
ABONNEZ-VOUS MAINTENANT
Pour en savoir plus sur les programmes de formation en essais cliniques au Canada, suivez notre développement et progrès mensuels
En m’inscrivant, j’ai lu et j’accepte les conditions d’utilisation et la politique de confidentialité